BackAeglea BioTherapeutics Overview

Aeglea BioTherapeutics Other Assets

Track Aeglea BioTherapeutics's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Aeglea BioTherapeutics Other Assets History

Loading

Aeglea BioTherapeutics vs. peers: Other Assets Comparison

Loading

Aeglea BioTherapeutics Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aeglea BioTherapeutics (AGLE) FAQ

Aeglea BioTherapeutics (AGLE) currently reports a other assets of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Aeglea BioTherapeutics's other assets history and peer comparisons.

Aeglea BioTherapeutics's other assets changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aeglea BioTherapeutics reported $0 in other assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aeglea BioTherapeutics, and consider following AGLE for alerts when major investors trade the stock.

Aeglea BioTherapeutics is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGLE with unrelated industries.